Isthmus Partners LLC Sells 14,100 Shares of DocGo Inc. (NASDAQ:DCGO)

Isthmus Partners LLC trimmed its stake in DocGo Inc. (NASDAQ:DCGO) by 2.2% during the 4th quarter, HoldingsChannel.com reports. The firm owned 623,928 shares of the company’s stock after selling 14,100 shares during the period. Isthmus Partners LLC’s holdings in DocGo were worth $2,645,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently made changes to their positions in DCGO. Centiva Capital LP acquired a new stake in DocGo during the third quarter worth about $43,000. Intech Investment Management LLC acquired a new stake in shares of DocGo during the 3rd quarter worth approximately $62,000. Victory Capital Management Inc. increased its position in shares of DocGo by 100.3% during the third quarter. Victory Capital Management Inc. now owns 51,349 shares of the company’s stock valued at $170,000 after purchasing an additional 25,714 shares during the period. SG Americas Securities LLC raised its stake in shares of DocGo by 12.9% in the fourth quarter. SG Americas Securities LLC now owns 43,052 shares of the company’s stock valued at $183,000 after purchasing an additional 4,905 shares in the last quarter. Finally, JPMorgan Chase & Co. lifted its position in DocGo by 151.1% in the third quarter. JPMorgan Chase & Co. now owns 109,855 shares of the company’s stock worth $365,000 after purchasing an additional 66,097 shares during the period. Institutional investors own 56.44% of the company’s stock.

Insider Transactions at DocGo

In other news, General Counsel Ely D. Tendler sold 23,088 shares of the company’s stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $4.44, for a total transaction of $102,510.72. Following the transaction, the general counsel now directly owns 175,645 shares in the company, valued at approximately $779,863.80. This represents a 11.62 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 2.70% of the company’s stock.

DocGo Price Performance

NASDAQ DCGO opened at $3.03 on Monday. The stock’s 50 day simple moving average is $4.45 and its 200 day simple moving average is $4.00. DocGo Inc. has a one year low of $2.75 and a one year high of $5.68. The firm has a market cap of $309.21 million, a PE ratio of 10.82, a price-to-earnings-growth ratio of 14.16 and a beta of 1.08.

Analyst Ratings Changes

DCGO has been the topic of several analyst reports. Deutsche Bank Aktiengesellschaft lowered shares of DocGo from a “buy” rating to a “hold” rating and lowered their price target for the company from $5.00 to $2.85 in a report on Friday, February 28th. Stifel Nicolaus decreased their price target on DocGo from $6.50 to $5.50 and set a “buy” rating on the stock in a research note on Friday, February 28th. Finally, Needham & Company LLC dropped their price objective on DocGo from $7.00 to $4.00 and set a “buy” rating for the company in a research note on Friday, February 28th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, DocGo currently has an average rating of “Moderate Buy” and a consensus price target of $4.89.

DocGo Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.